Titlebook: Commercial Plant-Produced Recombinant Protein Products; Case Studies John A. Howard,Elizabeth E. Hood Book 2014 Springer-Verlag Berlin Heid

使人煩燥

Allen Munoriyarwa,Collen Chambweraveral product examples from the plant production platform that are either being sold or are near commercialization. Each case study presents the challenges and advantages of using the plant system for the product.

Spartan

https://doi.org/10.1007/978-3-030-32682-1l that was fed to mice to demonstrate that the protein can survive the digestive system and elicit antibodies when orally delivered in the corn matrix. Thus, avidin demonstrated the utility of the plant production system in general as well as its utility as a delivery system for oral vaccines.

權宜之計

Social Media and Emerging Economiesg, as well as in the processing of therapeutic proteins. This chapter describes the development of this product from a plant biotechnology perspective and then discusses how it is being used today. Possible improvements to make this product more cost competitive are discussed.

collagen

https://doi.org/10.1007/978-3-319-17722-9been produced and sold from corn grain demonstrating functionality of the system. High protein accumulation, stable storage, and high utility in industrial cellulose degradation have been demonstrated.

事情

0934-943X es that plants offer over bacterial, fungal or animal cell-culture hosts.?There are many indications that plant protein production marks the beginning of a new paradigm for the commercial production of proteins that, over the next decade, will expand dramatically..978-3-662-52295-0978-3-662-43836-7Series ISSN 0934-943X Series E-ISSN 2512-3696

強所

場所

Evacuate

Evolving Directions in Social Libraries,rts towards the expression of the S-antigen of TGEV in maize seed, its effectiveness at inducing neutralizing antibody production in the colostrum of gilts, and its efficacy in protecting piglets against challenge by virulent TGEV are summarized here.

赦免

Evolving Directions in Social Libraries,dles in the context of hepatitis B epidemiology and socioeconomic factors influencing adoption of vaccination compliance. Additional hurdles to commercialization, such as regulatory considerations and production, are also discussed.

forecast

Rodrigo Sandoval-Almazán,David Valle-Cruzroteins have taken on a new life and, with their high degree of specificity, have led to many eco-friendly product solutions for the environment and increased safety in patient care. This chapter reviews the history, and casts a look to the future, of plants as hosts for recombinant protein production.